Merck & Co., Inc. (MRK) operating KPIs
MRKNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026Score 9/30242% above fair value
$146.33+5.40 (+3.83%)
Close on Oct 29, 2026Market cap $361.02BP/E 117.1Yield 2.24%
Latest, Q2 2026
-0.54
Period ended Jun 30, 2026
Change on a year earlier
-130.7%
1.76 in Q2 2025
History
51 quarters
Since Q2 2008
Sources
48
Documents cited below
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Basic EPS ($) ($) | Year on year | Source |
|---|---|---|---|---|
| Q2 2026 | Jun 30, 2026 | -0.54 | -130.7% | Form 10-Q (filed 2026-08-07) ↗ |
| Q1 2026 | Mar 31, 2026 | -1.72 | -185.6% | Form 10-Q (filed 2026-05-04) ↗ |
| Q3 2025 | Sep 30, 2025 | 2.32 | +85.6% | Form 10-Q (filed 2025-11-05) ↗ |
| Q2 2025 | Jun 30, 2025 | 1.76 | -18.1% | Form 10-Q (filed 2025-08-05) ↗ |
| Q1 2025 | Mar 31, 2025 | 2.01 | +6.9% | Form 10-Q (filed 2025-05-02) ↗ |
| Q3 2024 | Sep 30, 2024 | 1.25 | -33.2% | Form 10-Q (filed 2024-11-06) ↗ |
| Q2 2024 | Jun 30, 2024 | 2.15 | -191.5% | Form 10-Q (filed 2024-08-05) ↗ |
| Q1 2024 | Mar 31, 2024 | 1.88 | +69.4% | Form 10-Q (filed 2024-05-03) ↗ |
| Q3 2023 | Sep 30, 2023 | 1.87 | +46.1% | Form 10-Q (filed 2023-11-03) ↗ |
| Q2 2023 | Jun 30, 2023 | -2.35 | -250.6% | Form 10-Q (filed 2023-08-07) ↗ |
| Q1 2023 | Mar 31, 2023 | 1.11 | -34.7% | Form 10-Q (filed 2023-05-05) ↗ |
| Q3 2022 | Sep 30, 2022 | 1.28 | -29.3% | Form 10-Q (filed 2022-11-03) ↗ |
| Q2 2022 | Jun 30, 2022 | 1.56 | +155.7% | Form 10-Q (filed 2022-08-05) ↗ |
| Q1 2022 | Mar 31, 2022 | 1.70 | +34.9% | Form 10-Q (filed 2022-05-05) ↗ |
| Q3 2021 | Sep 30, 2021 | 1.81 | +56.0% | Form 10-Q (filed 2021-11-05) ↗ |
| Q2 2021 | Jun 30, 2021 | 0.61 | -48.7% | Form 10-Q (filed 2021-08-09) ↗ |
| Q1 2021 | Mar 31, 2021 | 1.26 | -0.8% | Form 10-Q (filed 2021-05-05) ↗ |
| Q3 2020 | Sep 30, 2020 | 1.16 | +56.8% | Form 10-Q (filed 2020-11-05) ↗ |
| Q2 2020 | Jun 30, 2020 | 1.19 | +14.4% | Form 10-Q (filed 2020-08-05) ↗ |
| Q1 2020 | Mar 31, 2020 | 1.27 | +12.4% | Form 10-Q (filed 2020-05-06) ↗ |
| Q3 2019 | Sep 30, 2019 | 0.74 | +1.4% | Form 10-Q (filed 2019-11-05) ↗ |
| Q2 2019 | Jun 30, 2019 | 1.04 | +62.5% | Form 10-Q (filed 2019-08-06) ↗ |
| Q1 2019 | Mar 31, 2019 | 1.13 | +318.5% | Form 10-Q (filed 2019-05-08) ↗ |
| Q3 2018 | Sep 30, 2018 | 0.73 | -3,750.0% | Form 10-Q (filed 2018-11-06) ↗ |
| Q2 2018 | Jun 30, 2018 | 0.64 | -9.9% | Form 10-Q (filed 2018-08-07) ↗ |
| Q1 2018 | Mar 31, 2018 | 0.27 | -51.8% | Form 10-Q (filed 2018-05-08) ↗ |
| Q3 2017 | Sep 30, 2017 | -0.02 | -102.5% | SEC Filing ↗ |
| Q2 2017 | Jun 30, 2017 | 0.71 | +61.4% | SEC Filing ↗ |
| Q1 2017 | Mar 31, 2017 | 0.56 | +36.6% | SEC Filing ↗ |
| Q3 2016 | Sep 30, 2016 | 0.79 | +21.5% | SEC Filing ↗ |
| Q2 2016 | Jun 30, 2016 | 0.44 | +83.3% | SEC Filing ↗ |
| Q1 2016 | Mar 31, 2016 | 0.41 | +20.6% | SEC Filing ↗ |
| Q3 2015 | Sep 30, 2015 | 0.65 | +109.7% | Form 10-Q (filed 2015-11-05) ↗ |
| Q2 2015 | Jun 30, 2015 | 0.24 | -65.2% | Form 10-Q (filed 2015-08-06) ↗ |
| Q1 2015 | Mar 31, 2015 | 0.34 | -41.4% | Form 10-Q (filed 2015-05-07) ↗ |
| Q3 2014 | Sep 30, 2014 | 0.31 | – | Form 10-Q (filed 2014-11-10) ↗ |
| Q2 2014 | Jun 30, 2014 | 0.69 | – | Form 10-Q (filed 2014-08-07) ↗ |
| Q1 2014 | Mar 31, 2014 | 0.58 | +9.4% | Form 10-Q (filed 2014-05-08) ↗ |
| Q1 2013 | Mar 31, 2013 | 0.53 | -7.0% | Form 10-Q (filed 2013-05-09) ↗ |
| Q3 2012 | Sep 30, 2012 | 0.57 | +3.6% | Form 10-Q (filed 2012-11-09) ↗ |
| Q2 2012 | Jun 30, 2012 | 0.59 | – | Form 10-Q (filed 2012-08-07) ↗ |
| Q1 2012 | Mar 31, 2012 | 0.57 | – | Form 10-Q (filed 2012-05-08) ↗ |
| Q3 2011 | Sep 30, 2011 | 0.55 | +400.0% | Form 10-Q (filed 2011-11-08) ↗ |
| Q3 2010 | Sep 30, 2010 | 0.11 | -93.2% | Form 10-Q (filed 2010-11-08) ↗ |
| Q2 2010 | Jun 30, 2010 | 0.24 | -67.6% | Form 10-Q (filed 2010-08-06) ↗ |
| Q1 2010 | Mar 31, 2010 | 0.10 | -85.1% | Form 10-Q (filed 2010-05-07) ↗ |
| Q3 2009 | Sep 30, 2009 | 1.62 | +362.9% | Form 10-Q (filed 2010-11-08) ↗ |
| Q2 2009 | Jun 30, 2009 | 0.74 | +184.6% | Form 10-Q (filed 2010-08-06) ↗ |
| Q1 2009 | Mar 31, 2009 | 0.67 | – | Form 10-Q (filed 2010-05-07) ↗ |
| Q3 2008 | Sep 30, 2008 | 0.35 | – | Form 10-Q (filed 2009-10-29) ↗ |
| Q2 2008 | Jun 30, 2008 | 0.26 | – | Form 10-Q (filed 2009-07-24) ↗ |
Cite this data
StockData. (2026). Merck Basic EPS ($) ($), quarterly Q2 2008–Q2 2026 [Data set]. Compiled from Merck SEC filings and investor materials. https://stockdatahq.com/stocks/mrk/kpis/db_inc_eps_b
See every metric in the Merck KPI table. Data updated Oct 26, 2026.